Basic Information
Basic information for LINC02018-225-18aa
Peptide Name LINC02018-225-18aa
Genome Position chr3:75443626-75443646,75446468-75446500[+]
Species Human
Peptide Sequence MKPWTLTVQAILLPQPPE
Peptide Length 18
Unique No (LINC02018-202-18aa,LINC02018-205-18aa,LINC02018-206-18aa,LINC02018-208-18aa,LINC02018-211-18aa-1,LINC02018-212-18aa,LINC02018-213-18aa,LINC02018-214-18aa,LINC02018-215-18aa,LINC02018-217-18aa,LINC02018-218-18aa,LINC02018-221-18aa,LINC02018-223-18aa,LINC02018-224-18aa,LINC02018-226-18aa,LINC02018-227-18aa,LINC02018-228-18aa-1,LINC02018-229-18aa,LINC02018-230-18aa,LINC02018-231-18aa,LINC02018-233-18aa,LINC02018-234-18aa,LINC02018-235-18aa,LINC02018-236-18aa,LINC02018-237-18aa-1)
Grand Average of Hydropathicity 0.0389
Relative Molecular Mass 2368.81
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000272690;LINC02018
Transcript ID/Name ENST00000662833;LINC02018-225
Transcript Length 1098
Coding Ability 0.2459
DNA Sequence Corresponding to Peptide ATGAAGCCGTGGACCCTCACGGTTCAAGCGATTCTCCTGCCTCAGCCTCCAGAG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :